Roles of interleukin-1 beta in glutamate-induced spinal cord injury

Date

2006-11-15

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Glutamate release contributes to the impairments caused by spinal cord injury (SCI). This study addresses the mechanisms of glutamate toxicity involving activation of interleukin-1â (IL-1â). To assess the effects of glutamate on IL-1â and its natural blocking agent interleukin-1 receptor antagonist (IL-1ra), ELISA assays were used to measure the responses of endogenous IL-1â and IL-1ra to glutamate administered to the spinal cord. Levels of activated IL-1â and IL-1ra changed in a reciprocal fashion starting 1 hour after glutamate exposure. Exposure to glutamate initially increases IL-1â expression while it decreases IL-1ra. IL-1â then decreases and IL-1ra increases. IL-1â and IL-1ra change reciprocally in the same fashion in a contused spinal cord. To check whether this mutual effect is due to actions of IL-1â and IL-1ra on each other, IL-1â was applied on the spinal cord and then IL-1ra was measured. IL-1ra was applied onto the cord and IL-1â was measured as well. The results show that administration of IL-1â stimulates the production of IL-1ra and administration of IL-1ra suppresses the activation of IL-1â. To identify subtypes of glutamate receptors involved in this phenomenon, NMDA and AMPA receptor agonists were separately applied to the spinal cord and IL-1â and IL-1ra expression in the cord were measured with ELISA assays. Activation of both the AMPA and the NMDA receptors also induced reciprocal changes between the IL-1â and IL-1ra levels. To determine the effects of activating AMPA and NMDA receptors on IL-1â and IL-1ra, MK801 and NBQX were applied individually on the spinal cord with glutamate. The results show that both AMPA and NMDA receptors are involved in glutamate-induced reciprocity between IL-1â and IL-1ra. To determine if this reciprocity between the expression of IL-1â and IL-1ra affected post-SCI locomotor function, recombinant IL-1â and IL-1ra were administered to glutamate-exposed spinal cords. The Basso-Beattie-Bresnahan (BBB) test of functional recovery demonstrated that IL-1â impaired rat locomotive ability and that IL-1ra improved the recovery of the rats from glutamate-induced locomotor impairment. To explore the mechanism of this IL-1â involvement in excitotoxicity, MAPK activities responding to glutamate were measured and the results showed that both ERK1/2 and p38 are involved in IL-1â induced SCI. Cell death assays showed that apoptosis is caused by glutamate-induced SCI. Overall, we established the following pathway from spinal cord injury to functional impairment: SCI → glutamate release → IL-1â and IL-1ra changes → ERK1/2 and p38 activation → cell death → functional impairment. This is the first pathway traced from glutamate release to functional impairments.

Description

Citation